Hard cancers have significantly higher GLUT1 expression, an indicator of hypoxia, and levels of prognostic biomarkers such as ER negativity, PR negativity, Ki67 positivity, high grade, and HER2-overexpressing and triple-negative molecular subtypes. Here, SLC2A1 is linked to cancer.